148 related articles for article (PubMed ID: 11785690)
1. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
Marro D; Kalia YN; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Dec; 18(12):1709-13. PubMed ID: 11785690
[TBL] [Abstract][Full Text] [Related]
2. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
Marro D; Kalia YN; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
[TBL] [Abstract][Full Text] [Related]
3. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
4. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.
Luzardo-Alvarez A; Delgado-Charro MB; Blanco-Méndez J
Pharm Res; 2001 Dec; 18(12):1714-20. PubMed ID: 11785691
[TBL] [Abstract][Full Text] [Related]
5. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility.
Abla N; Geiser L; Mirgaldi M; Naik A; Veuthey JL; Guy RH; Kalia YN
J Pharm Sci; 2005 Dec; 94(12):2667-75. PubMed ID: 16258982
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
7. Transport numbers in transdermal iontophoresis.
Mudry B; Guy RH; Delgado-Charro MB
Biophys J; 2006 Apr; 90(8):2822-30. PubMed ID: 16443654
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the iontophoretic permselectivity properties of human and pig skin.
Marro D; Guy RH; Delgado-Charro MB
J Control Release; 2001 Jan; 70(1-2):213-7. PubMed ID: 11166421
[TBL] [Abstract][Full Text] [Related]
9. Effects of vasoactive drugs on transdermal lidocaine iontophoresis.
Riviere JE; Sage B; Williams PL
J Pharm Sci; 1991 Jul; 80(7):615-20. PubMed ID: 1941556
[TBL] [Abstract][Full Text] [Related]
10. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
11. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
12. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.
Sekkat N; Kalia YN; Guy RH
Pharm Res; 2004 Aug; 21(8):1390-7. PubMed ID: 15359573
[TBL] [Abstract][Full Text] [Related]
13. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
14. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches.
Hu L; Silva SM; Damaj BB; Martin R; Michniak-Kohn BB
Int J Pharm; 2011 Dec; 421(1):53-62. PubMed ID: 21963468
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-permeation relationship for iontophoretic transport across the skin.
Mudry B; Carrupt PA; Guy RH; Delgado-Charro MB
J Control Release; 2007 Sep; 122(2):165-72. PubMed ID: 17707106
[TBL] [Abstract][Full Text] [Related]
16. In vitro optimization of dexamethasone phosphate delivery by iontophoresis.
Sylvestre JP; Guy RH; Delgado-Charro MB
Phys Ther; 2008 Oct; 88(10):1177-85. PubMed ID: 18719003
[TBL] [Abstract][Full Text] [Related]
17. Transungual iontophoresis of lithium and sodium: effect of pH and co-ion competition on cationic transport numbers.
Dutet J; Delgado-Charro MB
J Control Release; 2010 Jun; 144(2):168-74. PubMed ID: 20153788
[TBL] [Abstract][Full Text] [Related]
18. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.
Gratieri T; Zarhloule R; Dubey S; Kalia YN
Int J Pharm; 2021 Jun; 602():120607. PubMed ID: 33862130
[TBL] [Abstract][Full Text] [Related]
19. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.
Lopez RF; Bentley MV; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Mar; 18(3):311-5. PubMed ID: 11442270
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
